Crouch E, Parghi D, Kuan S F, Persson A
Department of Pathology, Jewish Hospital, Washington University Medical Center, St. Louis, Missouri 63110.
Am J Physiol. 1992 Jul;263(1 Pt 1):L60-6. doi: 10.1152/ajplung.1992.263.1.L60.
Surfactant protein D (SP-D, CP4) is a collagenous surfactant-associated carbohydrate binding protein that was initially characterized as a biosynthetic product of type II pneumocytes. Immunoperoxidase studies of formaldehyde solution-fixed and paraffin-embedded rat lung demonstrated staining for SP-D in the cytoplasm of a subpopulation of bronchiolar epithelial cells as well as type II cells. Accordingly, immunogold-labeling techniques were used to further examine the cellular distribution and subcellular localization of SP-D in the small airways. Lung tissues were fixed with 0.5% glutaraldehyde-3% paraformaldehyde and embedded in LR White resin. Sections were reacted with affinity purified polyclonal antibodies to SP-D, and sites of antibody binding were demonstrated using a biotinylated secondary antibody-streptavidin-gold detection system. Anti-SP-D selectively decorated secretory compartments of nonciliated bronchiolar cells (Clara cells) with strong and specific labeling of apical electron-dense secretory granules. Almost all of the granules in nonciliated columnar cells were labeled; however, labeling was typically nonuniform, with preferential decoration of the periphery of the granule. The largest numbers of immunoreactive epithelial cells were observed in the distal membranous bronchioles, with progressively smaller numbers of cells in more proximal bronchioles. There was no detectable labeling of cells lining the large cartilagenous airways or trachea. These studies provide evidence that SP-D is a secretory product of nonciliated bronchiolar cells. We suggest that Clara cell-derived SP-D is a component of bronchiolar lining material, consistent with our hypothesis that SP-D contributes to surfactant metabolism and/or host defense within small airways.
表面活性蛋白D(SP-D,CP4)是一种与表面活性剂相关的胶原性碳水化合物结合蛋白,最初被鉴定为II型肺细胞的生物合成产物。对甲醛溶液固定、石蜡包埋的大鼠肺组织进行免疫过氧化物酶研究,结果显示细支气管上皮细胞亚群以及II型细胞的细胞质中有SP-D染色。因此,采用免疫金标记技术进一步研究了SP-D在小气道中的细胞分布和亚细胞定位。肺组织用0.5%戊二醛-3%多聚甲醛固定,包埋于LR White树脂中。切片与抗SP-D的亲和纯化多克隆抗体反应,使用生物素化二抗-链霉亲和素-金检测系统显示抗体结合位点。抗SP-D选择性地标记了无纤毛细支气管细胞(克拉拉细胞)的分泌区,顶端电子致密分泌颗粒有强烈且特异性的标记。几乎所有无纤毛柱状细胞中的颗粒都被标记;然而,标记通常不均匀,颗粒周边优先被标记。在远端膜性细支气管中观察到的免疫反应性上皮细胞数量最多,越靠近近端的细支气管中细胞数量逐渐减少。在大的软骨性气道或气管的内衬细胞中未检测到标记。这些研究提供了证据,表明SP-D是无纤毛细支气管细胞的分泌产物。我们认为,克拉拉细胞来源的SP-D是细支气管内衬物质的一个组成部分,这与我们的假设一致,即SP-D有助于小气道内的表面活性剂代谢和/或宿主防御。